Product Code: GVR-4-68038-798-8
Cardiac Monitoring And Cardiac Rhythm Management Devices Market Summary
The global cardiac monitoring and cardiac rhythm management devices market size was estimated at USD 30.05 billion in 2025 and is projected to reach USD 49.78 billion by 2033, growing at a CAGR of 6.55% from 2026 to 2033. The market growth is driven by the increasing prevalence of cardiovascular diseases and arrhythmias, the growing aging population, and the rising lifestyle-related risk factors.
The growing adoption of advanced cardiac monitoring solutions, such as wearable ECG devices, implantable loop recorders, and remote monitoring platforms, is enabling earlier diagnosis and continuous disease management outside of hospital settings. The technological advancements in CRM devices, including leadless and MRI-compatible pacemakers and next-generation ICDs, are enhancing clinical outcomes and device longevity, thereby supporting replacement demand and promoting broader adoption.
Increasing cardiovascular incidence is one of the key factors driving the growth of the cardiac monitoring and cardiac rhythm management industry. According to an Oxford Academic article published in January 2025, the global age-standardized prevalence of cardiovascular disease reaches approximately 7,179 cases per 100,000 people, highlighting the significant and ongoing impact of heart conditions worldwide. Such widespread prevalence means that millions are living with diseases that require careful monitoring and timely intervention to prevent complications. In September 2025, Philips introduced a new telemetry platform featuring the Telemetry Monitor 5500 to streamline cardiac monitoring and reduce non-actionable alarms. The system supports scalable, wearable monitoring, mobile workflows, and up to 30-day post-discharge cardiac tracking through its MCOT service.
Global Cardiac Monitoring And Cardiac Rhythm Management Devices Market Report Segmentation
This report forecasts revenue growth at the global, regional & country levels and analyzes the latest trends in each sub-segment from 2021 to 2033. For this report, Grand View Research has segmented the global cardiac monitoring and cardiac rhythm management devices market report based on product, end use, and region:
- Product Outlook (Unit Volume in '000 Units; Average Selling Price in USD per Unit; Revenue in USD Million, 2021 - 2033)
- Cardiac Monitoring Devices
- ECG
- Implantable Cardiac Monitors
- Holter Monitors
- Mobile Cardiac Telemetry
- Cardiac Rhythm Management Devices
- Pulse Generators
- Cardiac Resynchronization Therapy (CRT)
- CRT-Defibrillator
- CRT-Pacemakers
- Defibrillators
- Implantable Cardioverter Defibrillators (ICD)
- Transvenous Implantable Cardioverter Defibrillators (TIICDs)
- Single Chamber
- Dual Chamber
- Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)
- External Defibrillator.
- Pacemakers
- Conventional Pacemakers
- Leadless Pacemakers
- Leads
- Pacing Leads
- Standard RV/LV Leads
- Conduction System Pacing (CSP) / LBBAP Leads
- Defibrillator Leads
- Traditional Leads
- LV Leads
- End Use Outlook (Revenue USD Million, 2021 - 2033)
- Hospitals
- Ambulatory Surgery Centers
- Others
- Regional Outlook (Unit Volume in '000 Units; Average Selling Price in USD per Unit; Revenue in USD Million, 2021 - 2033)
- North America
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Latin America
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Segment Scope
- 1.1.2. Estimates and Forecast Timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased Database
- 1.3.2. GVR's Internal Database
- 1.3.3. Secondary Sources
- 1.3.4. Primary Research
- 1.3.5. Details of Primary Research
- 1.4. Information or Data Analysis
- 1.4.1. Data Analysis Models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.7. Research Assumptions
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product Outlook
- 2.2.2. End Use Outlook
- 2.3. Competitive Insights
Chapter 3. Global Cardiac Monitoring and Cardiac Rhythm Management Devices Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Rising Cardiovascular Incidence
- 3.2.1.2. Increasing Awareness and Screening Programs for Cardiac Cases
- 3.2.1.3. Technological Advancements in Cardiac Monitoring & Rhythm Management Devices
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. High Cost Associated with Devices
- 3.2.2.2. Product Recalls
- 3.3. Global Cardiac Monitoring and Cardiac Rhythm Management: Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's Five Forces
- 3.3.2. PESTLE Analysis
- 3.4. Technology Landscape
- 3.5. Case Study Analysis
Chapter 4. Global Cardiac Monitoring and Cardiac Rhythm Management Devices Market Segment Analysis, By Product, 2021 - 2033
- 4.1. Definition and Scope
- 4.2. Product Market Share Analysis, 2025 & 2033
- 4.3. Segment Dashboard
- 4.4. Market Estimates and Forecasts by Product, 2021 - 2033
- 4.5. Cardiac Monitoring Devices
- 4.5.1. Market Estimates and Forecasts (Revenue), 2021 - 2033
- 4.5.2. Market Estimates and Forecasts (Unit Volume), 2021 - 2033
- 4.5.3. Average Selling Price Estimates & Forecasts
- 4.5.4. ECG
- 4.5.4.1. ECG Market Estimates and Forecasts (Revenue)
- 4.5.4.2. ECG Market Estimates and Forecasts (Unit Volume)
- 4.5.4.3. Average Selling Price Estimates & Forecasts
- 4.5.5. Implantable Cardiac Monitors
- 4.5.5.1. Revenue Estimates and Forecasts
- 4.5.5.2. Unit Volume Estimates and Forecasts
- 4.5.5.3. Average Selling Price Estimates & Forecasts
- 4.5.6. Holter Monitors
- 4.5.6.1. Revenue Estimates and Forecasts
- 4.5.6.2. Unit Volume Estimates and Forecasts
- 4.5.6.3. Average Selling Price Estimates & Forecasts
- 4.5.7. Mobile Cardiac Telemetry
- 4.5.7.1. Revenue Estimates and Forecasts
- 4.5.7.2. Unit Volume Estimates and Forecasts
- 4.5.7.3. Average Selling Price Estimates & Forecasts
- 4.6. Cardiac Rhythm Management Devices
- 4.6.1. Market Estimates and Forecasts (Revenue)
- 4.6.2. Market Estimates and Forecasts (Unit Volume)
- 4.6.3. Average Selling Price Estimates & Forecasts
- 4.6.4. Pulse Generators
- 4.6.4.1. Revenue Estimates and Forecasts
- 4.6.4.2. Unit Volume Estimates and Forecasts
- 4.6.4.3. Average Selling Price Estimates & Forecasts
- 4.6.5. Cardiac Resynchronization Therapy (CRT)
- 4.6.5.1. Revenue Estimates and Forecasts
- 4.6.5.2. Unit Volume Estimates and Forecasts
- 4.6.5.3. Average Selling Price Estimates & Forecasts
- 4.6.6. Defibrillators
- 4.6.6.1. Implantable Cardioverter Defibrillators (ICDs)
- 4.6.6.1.1. Transvenous ICDs
- 4.6.6.1.1.1. Single Chamber
- 4.6.6.1.1.2. Dual Chamber
- 4.6.6.1.2. Subcutaneous ICDs (S-ICDs)
- 4.6.7. Pacemakers
- 4.6.7.1. Conventional Pacemakers
- 4.6.7.2. Leadless Pacemakers
- 4.6.8. Leads
- 4.6.8.1. Pacing Leads
- 4.6.8.2. Defibrillator Leads
Chapter 5. Market Segment Analysis, By End Use, 2021 - 2033
- 5.1. Definition and Scope
- 5.2. End Use Market Share Analysis, 2025 & 2033
- 5.3. Segment Dashboard
- 5.4. Market Estimates and Forecasts by End Use
- 5.5. Hospitals
- 5.6. Ambulatory Surgery Centers
- 5.7. Others
Chapter 6. Market Segment Analysis, By Region, 2021 - 2033
- 6.1. Regional Market Overview
- 6.2. Regional Market Share Analysis, 2025 & 2033
- 6.3. Regional Market Dashboard
- 6.4. Regional Market Snapshot
- 6.5. North America
- 6.6. Europe
- 6.7. Asia Pacific
- 6.8. Latin America
- 6.9. Middle East & Africa
Chapter 7. Competitive Landscape
- 7.1. Recent Developments & Impact Analysis
- 7.2. Company Categorization
- 7.3. Company Profiles
- 7.3.1. Stryker
- 7.3.2. Medtronic
- 7.3.3. Abbott
- 7.3.4. Boston Scientific Corporation
- 7.3.5. Koninklijke Philips N.V.
- 7.3.6. ZOLL Medical Corporation
- 7.3.7. GE HealthCare
- 7.3.8. MicroPort Scientific Corporation
- 7.3.9. Nihon Kohden Corporation
- 7.3.10. Biotronik SE & Co. KG